
Stella Kim Yi
Examiner (ID: 16227, Phone: (571)270-5123 , Office: P/1742 )
| Most Active Art Unit | 1742 |
| Art Unit(s) | 1791, 1742 |
| Total Applications | 1087 |
| Issued Applications | 708 |
| Pending Applications | 102 |
| Abandoned Applications | 311 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17563422
[patent_doc_number] => 20220127571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => CELL POPULATIONS WITH IMPROVED PRODUCTION AND THERAPEUTIC CHARACTERISTICS
[patent_app_type] => utility
[patent_app_number] => 17/425935
[patent_app_country] => US
[patent_app_date] => 2020-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17425935
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/425935 | CELL POPULATIONS WITH IMPROVED PRODUCTION AND THERAPEUTIC CHARACTERISTICS | Jan 27, 2020 | Abandoned |
Array
(
[id] => 20356290
[patent_doc_number] => 12472269
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Liver-specific inducible promoters and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/423693
[patent_app_country] => US
[patent_app_date] => 2020-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 21
[patent_no_of_words] => 22191
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423693
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/423693 | Liver-specific inducible promoters and methods of use thereof | Jan 19, 2020 | Issued |
Array
(
[id] => 17444076
[patent_doc_number] => 20220064581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => FUNCTIONALIZED SUBSTRATE TO MANIPULATE CELL FUNCTION AND DIFFERENTIATION
[patent_app_type] => utility
[patent_app_number] => 17/423246
[patent_app_country] => US
[patent_app_date] => 2020-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13856
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423246
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/423246 | FUNCTIONALIZED SUBSTRATE TO MANIPULATE CELL FUNCTION AND DIFFERENTIATION | Jan 16, 2020 | Pending |
Array
(
[id] => 17460262
[patent_doc_number] => 20220073567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => ACINETOBACTER BAUMANNII BACTERIOPHAGE MIKAB48 OR LYTIC PROTEIN DERIVED FROM THE BACTERIOPHAGE
[patent_app_type] => utility
[patent_app_number] => 17/417123
[patent_app_country] => US
[patent_app_date] => 2019-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17417123
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/417123 | ACINETOBACTER BAUMANNII BACTERIOPHAGE MIKAB48 OR LYTIC PROTEIN DERIVED FROM THE BACTERIOPHAGE | Dec 22, 2019 | Abandoned |
Array
(
[id] => 17299873
[patent_doc_number] => 20210395712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => OPTIMIZED GALC GENES AND EXPRESSION CASSETTES AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 17/416559
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18488
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416559
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416559 | Optimized GALC genes and expression cassettes and their use | Dec 19, 2019 | Issued |
Array
(
[id] => 17482640
[patent_doc_number] => 20220090144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => CHARACTERIZATION AND INACTIVATION OF ENDOGENOUS RETROVIRUSES IN CHINESE HAMSTER OVARY CELLS
[patent_app_type] => utility
[patent_app_number] => 17/417131
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17417131
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/417131 | Characterization and inactivation of endogenous retroviruses in chinese hamster ovary cells | Dec 19, 2019 | Issued |
Array
(
[id] => 19609038
[patent_doc_number] => 12157905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => CRISPR gene therapy of fusion gene related cancers
[patent_app_type] => utility
[patent_app_number] => 17/312808
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7722
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17312808
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/312808 | CRISPR gene therapy of fusion gene related cancers | Dec 17, 2019 | Issued |
Array
(
[id] => 17355385
[patent_doc_number] => 20220016181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => IMMUNOMODULATORY CELLS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/413314
[patent_app_country] => US
[patent_app_date] => 2019-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57747
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -142
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17413314
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/413314 | IMMUNOMODULATORY CELLS AND USES THEREOF | Dec 12, 2019 | Pending |
Array
(
[id] => 17428699
[patent_doc_number] => 20220056407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => CELL
[patent_app_type] => utility
[patent_app_number] => 17/312755
[patent_app_country] => US
[patent_app_date] => 2019-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17312755
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/312755 | CELL | Dec 12, 2019 | Abandoned |
Array
(
[id] => 17414300
[patent_doc_number] => 20220049204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => METHODS OF MANUFACTURING CELL BASED PRODUCTS USING SMALL VOLUME PERFUSION PROCESSES
[patent_app_type] => utility
[patent_app_number] => 17/312783
[patent_app_country] => US
[patent_app_date] => 2019-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18445
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17312783
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/312783 | METHODS OF MANUFACTURING CELL BASED PRODUCTS USING SMALL VOLUME PERFUSION PROCESSES | Dec 9, 2019 | Pending |
Array
(
[id] => 18141167
[patent_doc_number] => 20230015009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => Methods of Decellularization and Recellularization of Organs and Portions of Organs
[patent_app_type] => utility
[patent_app_number] => 17/781843
[patent_app_country] => US
[patent_app_date] => 2019-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -57
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781843
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781843 | Methods of Decellularization and Recellularization of Organs and Portions of Organs | Dec 3, 2019 | Pending |
Array
(
[id] => 19609030
[patent_doc_number] => 12157897
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Vectors for protein manufacture
[patent_app_type] => utility
[patent_app_number] => 17/299542
[patent_app_country] => US
[patent_app_date] => 2019-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 9
[patent_no_of_words] => 14248
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299542
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/299542 | Vectors for protein manufacture | Dec 3, 2019 | Issued |
Array
(
[id] => 17460600
[patent_doc_number] => 20220073905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => METHODS AND MATERIALS FOR SINGLE CELL TRANSCRIPTOME-BASED DEVELOPMENT OF AAV VECTORS AND PROMOTERS
[patent_app_type] => utility
[patent_app_number] => 17/416601
[patent_app_country] => US
[patent_app_date] => 2019-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416601
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416601 | METHODS AND MATERIALS FOR SINGLE CELL TRANSCRIPTOME-BASED DEVELOPMENT OF AAV VECTORS AND PROMOTERS | Dec 3, 2019 | Abandoned |
Array
(
[id] => 18194647
[patent_doc_number] => 20230048166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => FUSOSOME COMPOSITIONS FOR HEMATOPOIETIC STEM CELL DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/293797
[patent_app_country] => US
[patent_app_date] => 2019-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 118412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -53
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293797
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/293797 | FUSOSOME COMPOSITIONS FOR HEMATOPOIETIC STEM CELL DELIVERY | Nov 13, 2019 | Pending |
Array
(
[id] => 19564758
[patent_doc_number] => 12139519
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => CRY2 variant having increased photosensitivity and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/293568
[patent_app_country] => US
[patent_app_date] => 2019-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 18
[patent_no_of_words] => 6378
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293568
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/293568 | CRY2 variant having increased photosensitivity and use thereof | Nov 12, 2019 | Issued |
Array
(
[id] => 17336421
[patent_doc_number] => 20220002752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => RECOMBINANT VECTORS COMPRISING GENES FOR BINDING DOMAINS AND SECRETABLE PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/292357
[patent_app_country] => US
[patent_app_date] => 2019-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292357
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/292357 | RECOMBINANT VECTORS COMPRISING GENES FOR BINDING DOMAINS AND SECRETABLE PEPTIDES | Nov 12, 2019 | Abandoned |
Array
(
[id] => 17292546
[patent_doc_number] => 20210388385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => SYNP27 (PROB12), A PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN PROTOPLASMIC ASTROCYTES
[patent_app_type] => utility
[patent_app_number] => 17/287379
[patent_app_country] => US
[patent_app_date] => 2019-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9594
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287379
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/287379 | SYNP27 (PROB12), A PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN PROTOPLASMIC ASTROCYTES | Oct 23, 2019 | Abandoned |
Array
(
[id] => 18036525
[patent_doc_number] => 20220380740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => CONSTRUCTS FOR IMPROVED HDR-DEPENDENT GENOMIC EDITING
[patent_app_type] => utility
[patent_app_number] => 17/288504
[patent_app_country] => US
[patent_app_date] => 2019-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61836
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17288504
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/288504 | CONSTRUCTS FOR IMPROVED HDR-DEPENDENT GENOMIC EDITING | Oct 23, 2019 | Pending |
Array
(
[id] => 17258495
[patent_doc_number] => 20210371480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION AND OTHER DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/288311
[patent_app_country] => US
[patent_app_date] => 2019-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33968
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -119
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17288311
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/288311 | COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION AND OTHER DISEASES | Oct 22, 2019 | Abandoned |
Array
(
[id] => 17299891
[patent_doc_number] => 20210395730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => Selective Curbing of Unwanted RNA Editing (SECURE) DNA Base Editor Variants
[patent_app_type] => utility
[patent_app_number] => 17/284043
[patent_app_country] => US
[patent_app_date] => 2019-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23797
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17284043
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/284043 | Selective Curbing of Unwanted RNA Editing (SECURE) DNA Base Editor Variants | Oct 9, 2019 | Pending |